Bill116th CongressFiled Jun 4, 2019Health
S. 1712
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Jun 4, 2019)
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 or the DISARM Act of 2019
This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.
What just happenedJun 4, 2019
Read twice and referred to the Committee on Finance.
Who’s behind it
Sen. Isakson, Johnny [R-GA](R-GA)Sponsor
3 cosponsors3 D
3cosponsors1committees2actions1related bills6subjects
- Introduced in SenateJun 4, 2019
- Jun 4, 2019IntroReferral
Read twice and referred to the Committee on Finance.
Finance Committee - Jun 4, 2019IntroReferral10000
Introduced in Senate